Geneart Gets Grant to Participate in HIV Vaccine Development

Mar 18, 2008

NEW YORK (GenomeWeb News) – Geneart said yesterday that the European Commission has awarded it€300,000 ($470,000) under its 7^th Framework Program to participate in a project called "New HIV Vaccines Inducing Broadly Reactive Neutralizing Antibodies."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Main menu